 |
|
|
Clinical Department
Egret Pharma is establishing a clinical team to lead the study of drug candidates in normal and diseased individuals in China in accordance to the pathways established by the International Code on Harmonization (ICH guidelines) for good clinical practice (GCP). Egret is committed to bringing potent and affordable medications that will advance medical standards in the Chinese market. The medical team will work closely with the clinical experts of its US partners, top Chinese medical centers and contract research organizations. With its ability to carry out study design, protocol creation and the implementation, monitoring, and data analysis of clinical studies, Egret’s medical team will conduct clinical trials that both satisfy SFDA regulatory requirements and conform to ICH GCP guidelines.
|
 |
